Sign Out
SEDOL (Etoposide Injection USP) is indicated in the management of the following neoplasms: Refractory Testicular Tumors: Etoposide For Injection in combination therapy with other approved chemotherapeutic agents in patients with refractory testicular tumors who have already received appropriate surgical, chemotherapeutic, and radio therapeutic therapy.
Small Cell Lung Cancer: Etoposide For Injection and/or Capsules in combination with other cancer. Etoposide is indicated in approved chemotherapeutic agents as first line treatment in patients with small cell lung cancer.
